Vaxart Inc (VXRT)

概要ニュース株価時系列オプションチェーン Financials ディスカッション予測株式分割株の配当実績

Vaxart Inc (VXRT) 最新ニュース

Vaxart Inc (VXRT)

Vaxart Inc (VXRT) 最新ニュース

Vaxart Solicits Proxies from Shareholders - marketscreener.com

[DFAN14A] Vaxart, Inc. SEC Filing - Stock Titan

Vaxart Mails a Letter to Shareholders - marketscreener.com

Vaxart Urges Shareholders to Vote “FOR” ALL Six of the Company’s Highly Qualified Director Nominees on the WHITE Proxy Card TODAY - Yahoo Finance

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds Vaxart (VXRT) Investors of Securities Fraud Class Action and Encourages Investors with Significant Losses to Contact the Firm, Application Deadline Approaching - TMX Newsfile

Vaxart Files Definitive Proxy Statement and Mails Letter to Shareholders - The Manila Times

Vaxart Shareholder Alert - TMX Newsfile

Vaxart (NASDAQ: VXRT) Board rebuffs activist slate in contested proxy - Stock Titan

Vaxart director Mark Watson buys $6,530 in company stock By Investing.com - Investing.com South Africa

Vaxart director Mark Watson buys $6,530 in company stock - Investing.com UK

Vaxart, Inc. (VXRT) director adds 10,000 shares in open‑market buy - Stock Titan

Vaxart | 4: Statement of changes in beneficial ownership of securities-Officer Lo Steven - Moomoo

Daniel P. Houle Solicits Proxies from Shareholders of Vaxart - marketscreener.com

Activist group (VXRT) with 1.52M shares seeks majority on Vaxart board via GOLD proxy - Stock Titan

Vaxart (NASDAQ: VXRT) CFO uses 31,395 shares to cover RSU taxes - Stock Titan

Vaxart faces proxy contest ahead of July annual meeting By Investing.com - Investing.com Australia

Vaxart, Inc Provides Information to the Shareholders - marketscreener.com

Vaxart Emphasizes Board Stability and Oral Vaccine Platform Progress Ahead of 2026 Shareholder Vote - Minichart

Vaxart faces proxy contest ahead of July annual meeting - Investing.com UK

Vaxart Urges Shareholder Support Amid Proxy Contest, Updates Pipeline - TipRanks

VXRT: Oral pill vaccine platform advances with strong clinical data and extended financial runway - TradingView

Vaxart (NASDAQ: VXRT) proxy fight — Board backs six nominees, urges WHITE card - Stock Titan

Vaxart files preliminary proxy, urges support for board as Phase 2b COVID readout, $61M cash runway into Q2 2027 - TradingView

Vaxart (VXRT) readies contested 2026 vote as trial advances and runway extends to 2027 - Stock Titan

Vaxart (VXRT) registers 32.9M shares; up to $25M of issuer financing - Stock Titan

Vaxart Files Preliminary Proxy Statement and Issues Open Letter to Shareholders - GlobeNewswire

[EFFECT] Vaxart, Inc. SEC Filing - Stock Titan

[S-1/A] Vaxart, Inc. Amends IPO Registration Statement - Stock Titan

Vaxart (VXRT) Institutional Ownership 2026 $VXRT - MarketBeat

Complete Defense Verdict in Rare Securities Class Action Trial - Cornerstone Research

MSN Money - MSN

Vaxart anticipates early 2027 primary efficacy readout while aiming for Q2 sentinel data release - MSN

Earnings call transcript: Vaxart’s mixed Q1 2026 results, EPS beats forecast - Investing.com India

Vaxart (VXRT) Reports Progress in Clinical Programs and Financia - GuruFocus

VXRT: Revenue surged and net income turned positive as clinical milestones and funding flexibility advanced - TradingView

Earnings call transcript: Vaxart’s mixed Q1 2026 results, EPS beats forecast By Investing.com - Investing.com South Africa

VXRT: Revenue doubled year-over-year, with clinical milestones and cash runway into Q2 2027 - TradingView

[S-1] Vaxart, Inc. Files IPO Registration Statement - Stock Titan

Vaxart Q1 2026 Earnings Call Transcript - MarketBeat

Vaxart : Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q) - marketscreener.com

VXRT: Returned to profitability in Q1 2026 with strong revenue growth and improved cash position - TradingView

Vaxart targets Q2 data from 400-person oral COVID vaccine study - Stock Titan

Vaxart Provides Business Update and Reports First Quarter 2026 Financial Results - The Manila Times

Vaxart, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

Vaxart (OTCQX: VXRT) swings to Q1 2026 profit on BARDA and collaboration revenue - Stock Titan

Vaxart (OTCQX: VXRT) swings to Q1 2026 profit as COVID trial advances - Stock Titan

Vaxart (VXRT) files ATM supplement to raise up to $49.8M via Sales Agents - Stock Titan

VXRTに似た銘柄